Neuroleptic malignant syndrome.

The Medical Journal of Australia
T J Ingall, C Tennant

Abstract

The neuroleptic malignant syndrome is a relatively rare but potentially fatal complication of the use of major tranquillizers; mortality may be as high as 20%. The syndrome is manifest by the onset of hyperpyrexia, muscular rigidity and tremor, impaired consciousness and autonomic dysfunction. The pathophysiology is thought to be by way of dopamine receptor blockade. The syndrome is managed by cessation of the neuroleptic medication, by supportive measures and by instituting treatment with one or more of a number of specific drugs whose use is based on theoretical considerations rather than empirical evidence of efficacy; these drugs include anticholinergics, L-dopa, bromocriptine amantidine and dantrolene sodium. Although not proven, early recognition and treatment may reduce both the mortality and the longer term morbidity of this syndrome.

References

Jul 18, 1985·The New England Journal of Medicine·B H Guzé, L R Baxter
Jan 1, 1985·Comprehensive Psychiatry·L B Greenberg, K Gujavarty
Feb 1, 1980·Psychological Medicine·C D Marsden, P Jenner
May 1, 1981·The Journal of Nervous and Mental Disease·M ToruK Sugano
Jan 1, 1984·Clinical Neuropharmacology·R KurlanI Shoulson
Jun 1, 1984·Drug Intelligence & Clinical Pharmacy·L J Birkhimer, C L DeVane
Jan 7, 1984·The Medical Journal of Australia·W KnezevicA Fisher
Aug 18, 1983·The New England Journal of Medicine·T E Nelson, E H Flewellen

❮ Previous
Next ❯

Citations

Jan 1, 1992·Current Medical Research and Opinion·L HeikkiläV Pedersen
Oct 1, 1991·Australian and New Zealand Journal of Medicine·A Henderson, P Longdon
Jul 1, 1991·The Medical Journal of Australia·D C ReutensP R Goldswain
Apr 17, 1989·The Medical Journal of Australia·C H CantorD Dall'Asen
Jan 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·H D GoldwasserN M Spears
Jun 15, 1987·The Medical Journal of Australia·A Jee
Aug 3, 2005·Clinical Neuropharmacology· AdityanjeeKaizad R Munshi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

American Family Physician
A M Parikh, E G Camara
Drug Intelligence & Clinical Pharmacy
L J Birkhimer, C L DeVane
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
M V Balzan
© 2021 Meta ULC. All rights reserved